ADIPOQ and metabolic syndrome: In humans, higher circulating adiponectin is strongly associated with lower risk of type 2 diabetes,3 hepatic dysfunction4 and metabolic syndrome,5 although recent studies have cast doubt on whether adiponectin concentration is causally related to type 2 diabetes6 or coronary heart disease.7